PS Ratio
23.24
-0.85-3.53%
15 min ago
Summary
- As of February 7, 2025, NTLA price to sales ratio is 23.24, with a fall of -0.85 (-3.53%) during the most recent trading day.
- Over the past year, NTLA PS ratio has dropped by -44.16 (-65.52%).
- NTLA PS ratio is now -93.95% below its all-time high of 384.29.
Performance
NTLA PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
PS Ratio Formula
P/S = Market capitalization
TTM Revenue
Market capitalization
TTM Revenue
TTM Revenue
NTLA PS Ratio Trends
| PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | -3.5% | -3.5% | -3.5% | -6.3% |
| 1 m1 month | -23.1% | -23.1% | -23.1% | - |
| 3 m3 months | -38.9% | -38.9% | -38.9% | -6.3% |
| 6 m6 months | -50.9% | -54.1% | -53.9% | - |
| ytdytd | -15.6% | -15.6% | -15.6% | - |
| 1 y1 year | -65.5% | -62.6% | -59.0% | -16.8% |
| 5 y5 years | +46.5% | -27.8% | +46.4% | -0.0% |
NTLA PS Ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -23.1% | 22.19 | +4.7% | |
| 3 m | 3-month | 41.51 | -44.0% | 22.19 | +4.7% |
| 6 m | 6-month | 52.59 | -55.8% | 22.19 | +4.7% |
| 1 y | 1-year | 87.48 | -73.4% | 22.19 | +4.7% |
| 3 y | 3-year | 223.32 | -89.6% | 22.19 | +4.7% |
| 5 y | 5-year | 384.29 | -94.0% | 11.06 | +110.1% |
| alltime | all time | 384.29 | -94.0% | 11.06 | +110.1% |
Intellia Therapeutics PS Ratio History
| Date | Value |
|---|---|
| 2025 | 23.24(-15.6%) |
| 2024 | 27.54(-65.0%) |
| 2023 | 78.76(+35.1%) |
| 2022 | 58.31(-78.1%) |
| 2021 | 266.46(+328.9%) |
| Date | Value |
|---|---|
| 2020 | 62.13(+263.8%) |
| 2019 | 17.08(-12.6%) |
| 2018 | 19.54(-37.4%) |
| 2017 | 31.19(+8.9%) |
| 2016 | 28.65 |
FAQ
- What is Intellia Therapeutics price to sales ratio?
- What is the all time high PS ratio for Intellia Therapeutics?
- What is NTLA price to sales ratio year-to-date change?
- What is Intellia Therapeutics PS ratio year-on-year change?
What is Intellia Therapeutics price to sales ratio?
The current PS ratio of NTLA is 23.24
What is the all time high PS ratio for Intellia Therapeutics?
Intellia Therapeutics all-time high price to sales ratio is 384.29
What is NTLA price to sales ratio year-to-date change?
Intellia Therapeutics price to sales ratio has changed by -4.30 (-15.61%) since the beginning of the year
What is Intellia Therapeutics PS ratio year-on-year change?
Over the past year, NTLA price to sales ratio has changed by -44.16 (-65.52%)